Search research articles
Contact Us
Filters
Showing results (111-120 of 184) with videos related to
Page
of 19
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 25, 2000
A phase I study of gemcitabine and epirubicin for the treatment of platinum-resistant or refractory advanced ovarian cancer
S Pignata, E Varriale, G Casella, et al.
British Journal of Cancer
|
January 5, 2001
Carboplatin plus paclitaxel in extensive small cell lung cancer: a multicentre phase 2 study
C Gridelli, L Manzione, F Perrone, et al.
Anticancer Research
|
March 28, 2001
Carboplatin, cisplatin and paclitaxel in the treatment of patients with epithelial ovarian cancer
S De Placido, S Tramontana, E Ferrari, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 26, 2005
Weekly paclitaxel as first-line chemotherapy in elderly advanced breast cancer patients: a phase II study of the Gruppo Italiano di Oncologia Geriatrica (GIOGer)
L Del Mastro, F Perrone, L Repetto, et al.
ESMO Open
|
October 13, 2022
Subgroup analyses in randomized phase III trials of systemic treatments in patients with advanced solid tumours: a systematic review of trials published between 2017 and 2020
C Paratore, C Zichi, M Audisio, et al.
ESMO Open
|
August 3, 2022
Position paper of the Italian Association of Medical Oncology on the impact of COVID-19 on Italian oncology and the path forward: the 2021 Matera statement
G D Beretta, R Casolino, D C Corsi, et al.
International Journal of Oncology
|
April 30, 2011
Phase I study of carboplatin, cisplatin, and cyclophosphamide without and with lenograstim for the treatment of ovarian cancer
S Pignata, R Lauria, F Perrone, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 11, 2014
Treatment-related outcome of oropharyngeal cancer patients differentiated by HPV dictated risk profile: a tertiary cancer centre series analysis
P Bossi, E Orlandi, R Miceli, et al.
Targeted Oncology
|
July 4, 2013
Lack of KRAS, NRAS, BRAF and TP53 mutations improves outcome of elderly metastatic colorectal cancer patients treated with cetuximab, oxaliplatin and UFT
M Di Bartolomeo, F Pietrantonio, F Perrone, et al.
Oncology
|
November 29, 2008
Carboplatin and pegylated liposomal doxorubicin for advanced ovarian cancer: preliminary activity results of the MITO-2 phase III trial
S Pignata, G Scambia, A Savarese, et al.
Page
of 19
Search research articles
Search
Showing results (111-120 of 184) with videos related to
Sort By:
Page
of 19
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 25, 2000
A phase I study of gemcitabine and epirubicin for the treatment of platinum-resistant or refractory advanced ovarian cancer
S Pignata, E Varriale, G Casella, et al.
British Journal of Cancer
|
January 5, 2001
Carboplatin plus paclitaxel in extensive small cell lung cancer: a multicentre phase 2 study
C Gridelli, L Manzione, F Perrone, et al.
Anticancer Research
|
March 28, 2001
Carboplatin, cisplatin and paclitaxel in the treatment of patients with epithelial ovarian cancer
S De Placido, S Tramontana, E Ferrari, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 26, 2005
Weekly paclitaxel as first-line chemotherapy in elderly advanced breast cancer patients: a phase II study of the Gruppo Italiano di Oncologia Geriatrica (GIOGer)
L Del Mastro, F Perrone, L Repetto, et al.
ESMO Open
|
October 13, 2022
Subgroup analyses in randomized phase III trials of systemic treatments in patients with advanced solid tumours: a systematic review of trials published between 2017 and 2020
C Paratore, C Zichi, M Audisio, et al.
ESMO Open
|
August 3, 2022
Position paper of the Italian Association of Medical Oncology on the impact of COVID-19 on Italian oncology and the path forward: the 2021 Matera statement
G D Beretta, R Casolino, D C Corsi, et al.
International Journal of Oncology
|
April 30, 2011
Phase I study of carboplatin, cisplatin, and cyclophosphamide without and with lenograstim for the treatment of ovarian cancer
S Pignata, R Lauria, F Perrone, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 11, 2014
Treatment-related outcome of oropharyngeal cancer patients differentiated by HPV dictated risk profile: a tertiary cancer centre series analysis
P Bossi, E Orlandi, R Miceli, et al.
Targeted Oncology
|
July 4, 2013
Lack of KRAS, NRAS, BRAF and TP53 mutations improves outcome of elderly metastatic colorectal cancer patients treated with cetuximab, oxaliplatin and UFT
M Di Bartolomeo, F Pietrantonio, F Perrone, et al.
Oncology
|
November 29, 2008
Carboplatin and pegylated liposomal doxorubicin for advanced ovarian cancer: preliminary activity results of the MITO-2 phase III trial
S Pignata, G Scambia, A Savarese, et al.
Page
of 19